EC Number   |
Title |
Organism |
|---|
   3.4.24.B4 | A systematic computational analysis of human matrix metalloproteinase 13 (MMP-13) crystal structures and structure-based identification of prospective drug candidates as MMP-13 inhibitors repurposable for osteoarthritis |
Homo sapiens |
| 3.4.24.B4 | Activity of MMP1 and MMP13 and amino acid metabolism in patients with alcoholic liver cirrhosis |
Homo sapiens |
| 3.4.24.B4 | Cloning, expression, purification, and characterization of the catalytic domain of sika deer MMP-13 |
Cervus nippon |
| 3.4.24.B4 | Design, synthesis, and biological activity of novel, potent, and highly selective fused pyrimidine-2-carboxamide-4-one-based matrix metalloproteinase (MMP)-13 zinc-binding inhibitors |
Homo sapiens |
| 3.4.24.B4 | Oxidative stress-dependent MMP-13 activity underlies glucose neurotoxicity |
Danio rerio |
| 3.4.24.B4 | Oxidative stress-dependent MMP-13 activity underlies glucose neurotoxicity |
Mus musculus |
| 3.4.24.B4 | Refolding of recombinant histidine-tagged catalytic domain of MMP-13 from escherichia coli with ion-exchange chromatography for higher bioactivity |
Homo sapiens |
| 3.4.24.B4 | 3,4-Disubstituted benzofuran P1 MMP-13 inhibitors: optimization of selectivity and reduction of protein binding |
Homo sapiens |
| 3.4.24.B4 | 3-Hydroxy-4-arylsulfonyltetrahydropyranyl-3-hydroxamic acids are novel inhibitors of MMP-13 and aggrecanase |
Homo sapiens |
| 3.4.24.B4 | A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models |
Bos taurus |
